|Bid||44.85 x 500|
|Ask||44.90 x 200|
|Day's Range||44.65 - 45.72|
|52 Week Range||29.95 - 58.95|
|PE Ratio (TTM)||-31.26|
|Earnings Date||Aug 2, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||58.83|
The quest has seemed so elusive that it regularly draws comparison to the Holy Grail and unicorns.
PARSIPPANY, N.J., May 23, 2017-- Pacira Pharmaceuticals, Inc. today announced that James Scibetta is resigning as the company’ s president to become chief executive officer of an undisclosed private early-stage ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacira Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PCRX-US. Comparing the performance and risk of Pacira Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)